63
Participants
Start Date
October 17, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
December 31, 2025
SPH4336
SPH4336 Tablets ：Orally, 400mg once a day ; 28 days/cycle
Cadonilimab
Intravenous infusion, 6mg/Kg,28 days/cycle
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
The First Affiliated Hospital，Sun Yat-sen University, Guangzhou
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
RECRUITING
Xiangya Hospital Central South University, Changsha
RECRUITING
The Central Hospital of Yongzhou, Yongzhou
RECRUITING
Liaoning Cancer Hospital & Institute, Shenzhen
RECRUITING
Xijing Hospital, Xi’an
RECRUITING
West China Hospital，Sichuan University, Chengdu
RECRUITING
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang cancer Hospital, Hangzhou
RECRUITING
Peking Union Medical College Hospital, Beijing
RECRUITING
Peking University People's Hospital, Beijing
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Shanghai Sixth People's Hospital, Shanghai
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY